Mistral AI's funding round, while substantial, doesn't automatically mean it's the definitive informational context for a debate on the AI Act's viability.
We need a clear process for establishing what data points are truly foundational, not just whatever gets the most headlines; otherwise, we're building our analysis on anecdotes.
Who has the ownership of determining the evidentiary weight of such a transaction for the entire regulatory framework?
For instance, if a patient gets better after trying a specific diet, it doesn't mean that diet is the universal cure for all ailments, especially if other factors were involved in their recovery.
We need proper documentation outlining why this one financial event is considered almost necessary for understanding the regulatory impact.